VACCINATION SITE PRURITUS

VACCINATION SITE PRURITUS was reported 51 times

VACCINATION SITE PRURITUS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Skin Test Antigen [EPC] 8 0.0042
1 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
2 Human Immunoglobulin G [EPC] 5 0.0002
3 alpha-Glucosidase Inhibitor [EPC] 1 0.0002
4 Provitamin D2 Compound [EPC] 5 0.0002
5 Aromatic Amino Acid Decarboxylation Inhibitor [EPC] 4 0.0001
6 Aromatic Amino Acid [EPC] 4 0.0001
7 Integrin Receptor Antagonist [EPC] 4 0.0000
8 Aminosalicylate [EPC] 4 0.0000
9 Catecholamine [EPC] 2 0.0000
10 Expectorant [EPC] 4 0.0000
11 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
12 Androgen Receptor Inhibitor [EPC] 1 0.0000
13 Arteriolar Vasodilator [EPC] 1 0.0000
14 Anti-IgE [EPC] 1 0.0000
15 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
16 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
17 Sulfonylurea [EPC] 1 0.0000
18 Nonsteroidal Anti-inflammatory Drug [EPC] 10 0.0000
19 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
20 Platelet Aggregation Inhibitor [EPC] 4 0.0000
21 Osmotic Laxative [EPC] 2 0.0000
22 Interleukin-4 Receptor alpha Antagonist [EPC] 3 0.0000
23 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
24 Thiazide Diuretic [EPC] 1 0.0000
25 Vitamin C [EPC] 2 0.0000
26 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
27 Corticosteroid [EPC] 5 0.0000
28 Factor Xa Inhibitor [EPC] 1 0.0000
29 Kinase Inhibitor [EPC] 2 0.0000
30 Proton Pump Inhibitor [EPC] 2 0.0000
31 Vitamin D [EPC] 1 0.0000
32 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
33 Vitamin B12 [EPC] 1 0.0000
34 Benzodiazepine [EPC] 2 0.0000
35 GLP-1 Receptor Agonist [EPC] 1 0.0000
36 Insulin Analog [EPC] 1 0.0000
37 Atypical Antipsychotic [EPC] 1 0.0000
38 Loop Diuretic [EPC] 1 0.0000